StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Provention Bio Inc. (PRVB) to Resume Trading at 7:10 a.m.
May 28, 2021 7:08 AM
Provention Bio Inc ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Trading Halts
Next Articles
Provention Bio Inc. (PRVB) PT Lowered to $22.50 at Chardan Capital Markets Following FDA AdComm Vote
May 28, 2021 9:29 AM
Provention Bio (PRVB) Confirms FDA Advisory Committee Votes in Favor of Benefits of Teplizumab Outweighing Risks in Support of Approval to Delay Clinical Type 1 Diabetes
May 28, 2021 7:07 AM
Form 8-K Provention Bio, Inc. For: May 27
May 28, 2021 6:08 AM
FDA Advisory Committee Votes in Favor of the Benefits of Teplizumab Outweighing the Risks in Support of Approval to Delay Clinical Type 1 Diabetes (T1D)
May 27, 2021 9:45 PM
Provention Bio (PRVB) Announces Trading Halted Today for FDA Advisory Committee Meeting on Teplizumab
May 27, 2021 7:06 AM
